Form 4: ALX Oncology Interim CFO Shelly Pinto Sells Shares to Cover Tax Obligations

Sentiment:

SEC Form 4 Filing


Shelly Pinto, Interim CFO of ALX Oncology Holdings Inc., sold 1,426 shares of common stock on December 30, 2024, to satisfy tax obligations related to vesting restricted stock units.

Summary

  • On December 30, 2024, Shelly Pinto, the Interim CFO of ALX Oncology Holdings Inc., sold 1,426 shares of the company's common stock.
  • The shares were sold at a weighted average price of $1.5802.
  • The sale was executed to cover tax obligations arising from the vesting of restricted stock units.
  • Following the transaction, Pinto directly owns 90,123 shares of ALX Oncology Holdings Inc.
  • The price range for the shares sold was between $1.58 and $1.60.

Sentiment

Score: 5

Explanation: The document describes a routine transaction (sale of shares to cover tax obligations). It doesn't inherently indicate positive or negative sentiment regarding the company's prospects.

Industry Context

Sales of shares by company insiders are a common occurrence, often related to compensation or personal financial planning. It is important to consider the context of the sale, such as the reason for the sale and the amount of stock sold relative to the insider's total holdings.

Stakeholder Impact

  • The sale of shares by an insider could have a minor negative impact on shareholder sentiment, although the reason for the sale (tax obligations) is generally understood.

Key Dates

DateDescription
12/30/2024Date of stock sale transaction
01/02/2025Date of Form 4 filing

Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.